Investment Thesis
Aveanna demonstrates solid operational performance with strong 20.2% revenue growth and healthy profitability metrics, but faces concerning leverage with a 6.68x debt-to-equity ratio and weak interest coverage of 1.8x. The exceptional 115.7% ROE is artificially inflated by minimal equity base rather than operational excellence, masking underlying financial stress from high debt levels.
Strengths
- Strong revenue growth of 20.2% YoY indicating market expansion in home healthcare
- Solid profitability with 33.3% gross margin and 10.2% operating margin showing pricing power
- Positive free cash flow of $117.1M (4.8% FCF margin) with capex discipline
- Adequate liquidity with 1.32x current ratio supporting operational needs
Risks
- Dangerously high leverage at 6.68x debt-to-equity ratio with $1.3B long-term debt against $194.5M equity
- Weak interest coverage of 1.8x leaves minimal cushion for debt service in economic downturns
- Minimal equity base creates refinancing risk and limits financial flexibility for acquisitions or downturns
- Net income flat YoY (+0.0%) despite 20.2% revenue growth suggests margin compression or one-time items
- High insider trading activity (22 Form 4 filings in 90 days) warrants monitoring for potential concerns
Key Metrics to Watch
- Debt-to-equity ratio trending - critical threshold is maintaining below 5.0x
- Interest coverage ratio improvement - needs to exceed 2.5x for safety
- Operating margin sustainability - watch for margin compression in competitive markets
- Free cash flow growth relative to debt reduction - validate leverage improvement commitment
Financial Metrics
Revenue
2.4B
Net Income
225.0M
EPS (Diluted)
$1.05
Free Cash Flow
117.1M
Total Assets
2.0B
Cash
193.3M
Profitability Ratios
Gross Margin
33.3%
Operating Margin
10.5%
Net Margin
9.2%
ROE
115.7%
ROA
11.2%
FCF Margin
4.8%
Balance Sheet & Liquidity
Current Ratio
1.32x
Quick Ratio
1.32x
Debt/Equity
6.68x
Debt/Assets
90.3%
Interest Coverage
1.83x
Long-term Debt
1.3B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-20T10:42:11.419639 |
Data as of: 2026-01-03 |
Powered by Claude AI